An oral immunotherapy designed to treat dust mite allergy, made by Denmark's ALK-Abello, could soon become an option for thousands of people seeking treatment for persistent symptoms through the NHS.

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.